Several important updates surround the biotech corporation, Teleflex Incorporated (TFX). The company recently announced its third quarter earnings conference details, with several financial services companies adjusting their stock holdings in Teleflex, notable mentions include Franklin Resources Inc., Jane Street Group LLC, Geode Capital Management LLC and State Street Corp. Despite in-line reporting, the biotech firm experienced a drop in its stock value. The company is set to present at the 36th Annual Piper Sandler Healthcare Conference while analysts continue to update their estimates in light of the firm's recent third-quarter results. Teleflex's current financial standing and full-year outlook for 2024 have also been reported. However, the past three years have not been profitable for its investors, causing the stock to fall following a lowered 2024 revenue outlook. In the midst of this, Teleflex has chosen o9’s AI-powered platform for end-to-end integrated business planning and supply chain management, launched its next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada and expanded its CVC Portfolio in EMEA with a new launch. The CEO's compensation is considered agreeable with a current price target set at $252.50.
Teleflex Incorporated TFX News Analytics from Fri, 02 Dec 2016 08:00:00 GMT to Tue, 31 Dec 2024 09:06:49 GMT - Rating 0 - Innovation 2 - Information 5 - Rumor -3
